In a study conducted by Jun and colleagues, they employed adenoviral vectors carrying HSPA1A (encoding heat shock protein 70 [HSP70]) in gene therapy, which was applied to PD model induced by 1‐methyl‐4‐phenylpyridimium (MPP+). This evidence concerns the gene HSPA1A and Parkinson disease.